SAMDaily.us | SRCSGT | R | Post-Market Bioequivalence of Generic Drug Products

SAMDAILY.US - ISSUE OF FEBRUARY 15, 2023 SAM #7750
SOURCES SOUGHT

R -- Post-Market Bioequivalence of Generic Drug Products

Notice Date: 2/13/2023 11:27:53 AM
Notice Type: Sources Sought
NAICS: 541720 — Research and Development in the Social Sciences and Humanities
Contracting Office: FDA OFFICE OF ACQ GRANT SVCS Beltsville MD 20705 USA
ZIP Code: 20705
Solicitation Number: FDA-SSN-116253
Response Due: 2/23/2023 12:00:00 PM
Point of Contact: Ravi Chandan Palaniandy
E-Mail Address: Ravichandan.Palaniandy@fda.hhs.gov
(Ravichandan.Palaniandy@fda.hhs.gov)
Small Business Set-Aside: SBA Total Small Business Set-Aside (FAR 19.5)
Description: The objective of this project is to conduct appropriate Human Subject Research (HSR) studies of generic drug products in healthy subjects or patients as determined by the question of interest. Please see enclosed Attachment for full detail.
Web Link: SAM.gov Permalink
(https://sam.gov/opp/b35b70f17177486293b8c5cb21edfa02/view)
Place of Performance: Address: Silver Spring, MD 20993, USA; Zip Code: 20993; Country: USA
Record: SN06590377-F 20230215/230214060652 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |